Drug combo combats leukemia by attacking faulty cellular powerhouses

Researchers have homed in on new compounds that are effective at killing leukemia. The drug candidates shut down faulty mitochondria in the cancerous cells, and were found to be far more effective when paired with existing chemotherapy drugs.Continue R… Continue reading Drug combo combats leukemia by attacking faulty cellular powerhouses

Cancer drug pulls surprising double duty to treat muscular dystrophy

Duchenne Muscular Dystrophy (DMD) is a debilitating genetic disorder that eventually leaves patients in a wheelchair. In a new study, researchers have found that an existing cancer drug shows promise in slowing the progress of DMD by changing the type … Continue reading Cancer drug pulls surprising double duty to treat muscular dystrophy

Report estimates 10% of all cancers in Europe are caused by pollution

A new report from the European Environmental Agency estimates more than 10 percent of all cancer cases in Europe are likely caused by environmental and occupational exposure to pollution. The report indicates most of these cases could be prevented by i… Continue reading Report estimates 10% of all cancers in Europe are caused by pollution

Light-activated “photoimmunotherapy” kills brain cancer, reduces relapse

Scientists at the Institute of Cancer Research in London have developed a new light-activated “photoimmunotherapy” that could help treat brain cancer. The key is a compound that glows under light to guide surgeons to the tumor, while near-infrared ligh… Continue reading Light-activated “photoimmunotherapy” kills brain cancer, reduces relapse

Immunotherapy booster produces 10,000 times more cancer-fighting cells

Researchers at Washington University in St. Louis have found that adding a booster protein can significantly improve the outcome of cancer immunotherapy. Tests in mice showed the protein produced 10,000 times more immune cells, with all mice surviving … Continue reading Immunotherapy booster produces 10,000 times more cancer-fighting cells

Existing cancer drug boosts brain genes to improve memory and learning

Researchers at EPFL have found that an existing drug used to treat cancer, among other things, also seems to improve memory. Intriguingly, tests in mice show that the drug works by switching on genes associated with brain plasticity.Continue ReadingCat… Continue reading Existing cancer drug boosts brain genes to improve memory and learning

Existing cancer drug boosts brain genes to improve memory and learning

Researchers at EPFL have found that an existing drug used to treat cancer, among other things, also seems to improve memory. Intriguingly, tests in mice show that the drug works by switching on genes associated with brain plasticity.Continue ReadingCat… Continue reading Existing cancer drug boosts brain genes to improve memory and learning

Bursting bubbles create cell openings for potent delivery of cancer drugs

Microbubbles and ultrasound might seem like an odd couple, but recently we’ve seen these two forces combine to great effect in the world of medicine. A newly developed treatment makes use of these tools to deliver immunotherapy drugs with great potency… Continue reading Bursting bubbles create cell openings for potent delivery of cancer drugs

Experimental brain-on-a-chip better screens brain cancer treatments

The blood-brain barrier (BBB) is a vital line of defense to keep your brain safe from toxins, but frustratingly it can sometimes be too restrictive, keeping important drugs out. Researchers at MIT have now demonstrated an accurate new model of how this… Continue reading Experimental brain-on-a-chip better screens brain cancer treatments

Newly identified prostate cancer subtypes suggest new treatment options

Scientists at Weill Cornell Medicine have identified two new subtypes of prostate cancer. These new forms of the disease are resistant to usual treatments, but categorizing and studying them could lead to new therapies.Continue ReadingCategory: Medical… Continue reading Newly identified prostate cancer subtypes suggest new treatment options